Azithromycin prevents implantation failure via up-regulation of leukemia inhibitory factor in endotoxemic pregnant rats

Document Type : Original Article

Authors

1 Department of Genetics, Faculty of Veterinary Medicine, Selcuk University, Konya, Turkey

2 Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Selcuk University, Konya, Turkey

10.22038/ijbms.2025.85311.18435

Abstract

Objective(s): Embryonic implantation is a complex and poorly understood process in which numerous cellular, hormonal, and molecular factors play critical roles. Infections in this process can result in pregnancy failure, such as implantation failure, infertility, and spontaneous abortion. Antibiotic use is necessary for infections. However, antibiotic use in pregnancy and the effect of the drug used on implantation are also conditions that must be considered. The implantation site is highly sensitive to lipopolysaccharide (LPS) and tumor necrosis factor (TNF)α, both of which can induce embryonic resorption. This study aimed to determine the effect of azithromycin (AZIT) on implantation failure, an important factor in early embryonic loss caused by LPS, by evaluating TNFα, interleukin (IL)-10, IL-2, and leukemia inhibitory factor (LIF) mRNA expressions in uterine tissue.
Materials and Methods: The study involved twenty-six female rats, divided into four groups: Control, Sham, LPS, and LPS+AZIT. Lipopolysaccharide was administered intravenously on the 5th day of pregnancy in the LPS and LPS+AZIT groups. AZIT was administered intraperitoneally in the LPS+AZIT group simultaneously with LPS. TNFα, IL-10, IL-2, and LIF mRNA expressions were evaluated in uterine tissue three hours post-LPS administration. 
Results: Lipopolysaccharide administration increased the expression of TNFα and IL-2 and decreased the expression of LIF. AZIT prevented the LPS-induced increase in TNFα and IL-2 mRNA expression and the decrease in LIF mRNA expression, all of which are involved in implantation failure. 
Conclusion: AZIT may support the continuation of pregnancy by preventing the cytokine imbalance caused by infection at implantation.

Keywords

Main Subjects

References

1. Cañumil VA, Bogetti E, de la Cruz Borthiry FL, Ribeiro ML, Beltrame JS. Steroid hormones and first trimester vascular remodeling. In: Litwack G, editor. Vitamins and Hormones. California, Academic Press;  2021. p. 363-387. 
2. Kaicker A. Immune cells at the maternal-fetal interphase: Role in implantation and establishment of tolerance. J App Biol Biotech 2023; 11: 45-50. 
3. Tranguch S, Daikoku T, Guo Y, Wang H, Dey S. Molecular complexity in establishing uterine receptivity and implantation. Cell Mol Life Sci 2005; 62: 1964-1973. 
4. Zhang S, Lin H, Kong S, Wang S, Wang H, Wang H, et al. Physiological and molecular determinants of embryo implantation. Mol Aspects Med 2013; 34: 939-980. 
5. Hamid HY, Zakaria Z, Yimer N, Meng GY, Haron AW, Mustapha M. Effects of elevated ambient temperature on embryo implantation in rats. Afr J Biotechnol 2012; 11: 6624-6632. 
6. Kim SM, Kim JS. A review of mechanisms of implantation. Dev Reprod 2017; 21: 351-359. 
7. Pantos K, Grigoriadis S, Maziotis E, Pistola K, Xystra P, Pantou A, et al. The role of interleukins in recurrent implantation failure: A comprehensive review of the literature. Int J Mol Sci 2022; 23: 2198-2224. 
8. Moustafa S, Joseph DN, Taylor RN, Whirledge S. New models of lipopolysaccharide‐induced implantation loss reveal insights into the inflammatory response. Am J Reprod Immunol 2019; 81: e13082-13106. 
9. Robertson SA, Moldenhauer LM. Immunological determinants of implantation success. Int J Dev Biol 2014; 58: 205-217. 
10. Maybin JA, Critchley HO, Jabbour HN. Inflammatory pathways in endometrial disorders. Mol Cell Endocrinol 2011; 335: 42-51. 
11. Yang X, Tian Y, Zheng L, Luu T, Kwak-Kim J. The update immune-regulatory role of pro-and anti-inflammatory cytokines in recurrent pregnancy losses. Int J Mol Sci 2022; 24: 132-162. 
12. Robertson SA, Chin PY, Femia JG, Brown HM. Embryotoxic cytokines-Potential roles in embryo loss and fetal programming. J Reprod Immunol 2018; 125: 80-88.  
13. Kimber SJ. Leukaemia inhibitory factor in implantation and uterine biology. Reproduction 2005; 130: 131-145. 
14. Salleh N, Giribabu N. Leukemia inhibitory factor: Roles in embryo implantation and in nonhormonal contraception. Sci World J 2014; 2014: 201514-201524. 
15. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Köntgen F, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 76-79. 
16. Robertson SA, Care AS, Skinner RJ. Interleukin 10 regulates inflammatory cytokine synthesis to protect against lipopolysaccharide-induced abortion and fetal growth restriction in mice. Biol Reprod 2007; 76: 738-748.  
17. Er A. Azithromycin prevents pregnancy loss: Reducing the level of tumor necrosis factor-alpha and raising the level of interleukin-10 in rats. Mediators Inflamm 2013; 2013: 928137-928142. 
18. Toyama RP, Xikota JC, Schwarzbold ML, Frode TS, Buss ZdS, Nunes JC, et al. Dose-dependent sickness behavior, abortion and inflammation induced by systemic LPS injection in pregnant mice. J Matern Fetal Neonatal Med 2015; 28: 426-430. 
19. Er A, Dik B, Cetin G, Altan F, Uney K, Elmas M, et al. Etanercept-Can it be used in the treatment of endotoxemia? Kafkas Univ Vet Fak Derg 2013; 19: 133-139. 
20. Turgut K (ed).Veterinary Clinical Laboratory Diagnostics. Konya:Bahcıvanlar Press, 2000.
21. Antonucci R, Cuzzolin L, Locci C, Dessole F, Capobianco G. Use of azithromycin in pregnancy: More doubts than certainties. Clin Drug Investig 2022; 42: 921-935. 
22. Bahat Dinur A, Koren G, Matok I, Wiznitzer A, Uziel E, Gorodischer R, et al. Fetal safety of macrolides. Antimicrob Agents Chemother 2013; 57: 3307-3311. 
23. Er A, Yazar E. Effects of tylosin, tilmicosin and tulathromycin on inflammatory mediators in bronchoalveolar lavage fluid of lipopolysaccharide-induced lung injury. Acta Vet Hung 2012; 60: 465-476.
24. Er A, Aydin I, Dik B. Effect of anti-TNF-α on the development of offspring and pregnancy loss during pregnancy in rats. Acta Sci Vet 2016; 44: 1-6. 
25.Varano GP, Parisi V, Adornetto A, Cavaliere F, Amantea D, Nucci C, et al. Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat. Mol Vis 2017; 23: 911-921. 
26. Wang X, Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 2003; 31: e154-162.  
27. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001; 25: 402-408. 
28. Deb K, Reese J, Paria BC. Methodologies to study implantation in mice. Methods Mol Med 2006; 121: 9-34.  
29. Houser BL. Decidual macrophages and their roles at the maternal-fetal interface. Yale J Biol Med 2012; 85: 105-118.
30. Brown MB, von Chamier M, Allam AB, Reyes L. M1/M2 macrophage polarity in normal and complicated pregnancy. Front Immunol 2014; 5: 606-616.
31. Hussain T, Tan B, Liu G, Murtaza G, Rahu N, Saleem M, et al. Modulatory mechanism of polyphenols and Nrf2 signaling pathway in LPS challenged pregnancy disorders. Oxid Med Cell Longev 2017; 2017: 8254289-8254303. 
32. Jiang K, Yang J, Chen Y, Guo S, Zhao G, Wu H, et al. Protective effects of interferon-tau against lipopolysaccharide-induced embryo implantation failure in pregnant mice. J Interferon Cytokine Res 2018; 38: 226-234.  
33. Gui J, Xiong F, Li J, Huang G. Effects of acupuncture on Th1, Th2 cytokines in rats of implantation failure. Evid Based Complement Alternat Med 2012; 2012: 893023-893033. 
34. Renaud SJ, Cotechini T, Quirt JS, Macdonald-Goodfellow SK, Othman M, Graham CH. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J Immunol 2011; 186: 1799-1808. 
35. Javidan M, Changaei M, Tehrani FR, Mosaffa N, Noroozzadeh M, Hosseinzadeh R, et al. Altered expression of leukemia inhibitory factor (LIF), LIFR, gp130, and IL11 in the embryo implantation site of rat model with prenatal androgen-induced polycystic ovary syndrome. Biochem Biophys Res Commun 2022; 605: 24-30. 
36. Gui J, Xiong F, Yang W, Li J, Huang G. Effects of acupuncture on LIF and IL‐12 in rats of implantation failure. Am J Reprod Immunol 2012; 67: 383-390. 
37. Winship A, Correia J, Zhang JG, Nicola NA, Dimitriadis E. Leukemia inhibitory factor (LIF) inhibition during mid-gestation impairs trophoblast invasion and spiral artery remodelling during pregnancy in mice. PLoS One 2015; 10: e0129110-e0129123. 
38. Huang Q, Liu L, Hu B, Di X, Brennecke SP, Liu H. Decreased seizure threshold in an eclampsia-like model induced in pregnant rats with lipopolysaccharide and pentylenetetrazol treatments. PLoS One 2014; 9: e89333-89340.  
39. Oludare GO, Ilo OJ, Lamidi BA. Effects of lipopolysaccharide and high saline intake on blood pressure, angiogenic factors and liver enzymes of pregnant rats. Niger J Physiol Sci 2017; 32: 129-136. 
40. Muzaffar M, Sheikh A, Reshi M. Effect of curcumin on biochemical markers and histopathology examination of lps induced preeclampsia in experimental rats. AJPRD 2023; 11: 34-37. 
41. Van Amersfoort ES, Van Berkel TJ, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 2003; 16: 379-414. 
42. Keskin E, Oztekin E, Col R, Sivrikaya A, Uney K, Yazar E. Effect of pentoxifylline on antioxidant status of healthy and endotoxemic New Zealand white rabbits. Acta Vet Brno 2005; 74: 17-21. 
43. Zhou L, Li C, Liu X, Zhang T. Effect of irisin on LIF and integrin αvβ3 in rats of implantation failure. Reprod Biol Endocrinol 2021; 19: 18-25. 
44. Gholampour F, Roozbeh J, Janfeshan S, Karimi Z. Remote ischemic per-conditioning protects against renal ischemia-reperfusion injury via suppressing gene expression of TLR4 and TNF-α in rat model. Can J Physiol Pharmacol 2019; 97: 112-119. 
45. Liu Y, Xu D, Yin C, Wang S, Wang M, Xiao Y. IL-10/STAT3 is reduced in childhood obesity with hypertriglyceridemia and is related to triglyceride level in diet-induced obese rats. BMC Endocr Disord 2018; 18: 39-48.
Iranian Journal of Basic Medical Sciences
Volume 28, Issue 9
September 2025
Pages 1248-1253

Files

Share

How to cite

Statistics